CSTL
Castle Biosciences, Inc. NASDAQ Listed Jul 25, 2019$19.24
Mkt Cap $582.9M
52w Low $14.59
15.7% of range
52w High $44.28
50d MA $25.54
200d MA $28.54
P/E (TTM)
-29.9x
EV/EBITDA
92.4x
P/B
1.5x
Debt/Equity
0.1x
ROE
-5.1%
P/FCF
39.8x
RSI (14)
—
ATR (14)
—
Beta
1.19
50d MA
$25.54
200d MA
$28.54
Avg Volume
375.4K
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
505 South Friendswood Drive · Friendswood, TX 77546 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | -0.49 | -0.49 | +0.0% | 24.75 | -8.4% | -22.3% | — | — | — | — | — |
| Feb 26, 2026 | AMC | -0.23 | -0.08 | +65.2% | 31.88 | -6.3% | -7.2% | -5.3% | -1.5% | +2.2% | -0.9% | — |
| Nov 3, 2025 | AMC | -0.34 | -0.02 | +94.1% | 25.99 | +3.6% | +21.7% | +6.1% | -0.1% | -1.5% | +5.1% | — |
| Aug 4, 2025 | AMC | -0.51 | 0.15 | +129.4% | 15.32 | +29.6% | +32.8% | -2.9% | -0.6% | -1.5% | -1.0% | — |
| May 5, 2025 | AMC | -0.08 | -0.20 | -150.0% | 18.75 | -13.5% | -11.4% | +2.6% | +0.9% | -2.4% | +1.5% | — |
| Feb 27, 2025 | AMC | -0.04 | 0.32 | +900.0% | 25.28 | +2.8% | -14.2% | -1.9% | +4.5% | -4.1% | -3.4% | — |
| Nov 4, 2024 | AMC | -0.06 | 0.08 | +233.3% | 33.64 | +6.5% | -7.4% | +4.8% | +2.0% | -0.1% | +1.5% | — |
| Aug 5, 2024 | AMC | -0.27 | 0.31 | +214.8% | 21.85 | +20.1% | +14.0% | +7.7% | +3.8% | -3.6% | -0.3% | — |
| May 2, 2024 | AMC | -0.37 | -0.09 | +75.7% | 22.84 | +2.9% | +6.5% | +0.3% | -2.5% | -1.1% | +3.7% | — |
| Feb 28, 2024 | AMC | -0.84 | -0.10 | +88.1% | 24.39 | +1.9% | -26.0% | +10.4% | +6.5% | +5.1% | -3.8% | — |
| Nov 2, 2023 | AMC | -0.92 | -0.26 | +71.7% | 16.65 | +8.1% | +8.0% | +0.4% | -0.3% | -0.2% | -4.6% | — |
| Aug 2, 2023 | AMC | -1.01 | -0.70 | +30.7% | 16.79 | +11.2% | +11.8% | -1.4% | -3.3% | -1.0% | -0.2% | — |
| May 3, 2023 | AMC | -0.80 | -1.10 | -37.5% | 22.91 | -4.3% | -3.9% | +1.1% | +1.8% | +0.0% | +2.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $25.05 | $24.67 | -1.5% | +0.4% | -2.3% | +2.1% | -5.6% | +3.3% |
| Feb 27 | Baird | Maintains | Outperform → Outperform | — | $31.88 | $29.87 | -6.3% | -7.2% | -5.3% | -1.5% | +2.2% | -0.9% |
| Jan 26 | Guggenheim | Maintains | Buy → Buy | — | $42.24 | $42.25 | +0.0% | +1.9% | -0.5% | -7.8% | -0.9% | +0.6% |
| Jan 12 | Lake Street | Maintains | Buy → Buy | — | $39.34 | $40.80 | +3.7% | +0.8% | -0.1% | +2.9% | -0.0% | -1.8% |
| Jan 5 | Guggenheim | Maintains | Buy → Buy | — | $38.54 | $38.48 | -0.2% | +1.2% | +2.7% | +1.3% | -1.8% | -1.4% |
| Dec 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $39.44 | $40.00 | +1.4% | +4.9% | -2.9% | -0.3% | -1.7% | -0.3% |
| Dec 12 | BTIG | Maintains | Buy → Buy | — | $37.97 | $38.93 | +2.5% | +1.7% | +0.6% | +0.4% | +1.6% | -0.2% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $31.63 | $31.56 | -0.2% | +6.1% | -0.1% | -1.5% | +5.1% | +0.7% |
| Nov 4 | Baird | Maintains | Outperform → Outperform | — | $25.99 | $26.93 | +3.6% | +21.7% | +6.1% | -0.1% | -1.5% | +5.1% |
| Sep 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.06 | $24.24 | +0.7% | +2.5% | -6.9% | -0.8% | -5.8% | +0.9% |
| May 21 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $16.50 | $16.34 | -1.0% | -2.9% | -0.8% | +1.3% | -1.9% | +2.7% |
| May 6 | Lake Street | Maintains | Buy → Buy | — | $18.75 | $16.21 | -13.5% | -11.4% | +2.6% | +0.9% | -2.4% | +1.5% |
| May 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $18.75 | $16.21 | -13.5% | -11.4% | +2.6% | +0.9% | -2.4% | +1.5% |
| Feb 28 | Baird | Maintains | Outperform → Outperform | — | $25.28 | $26.00 | +2.8% | -14.2% | -1.9% | +4.5% | -4.1% | -3.4% |
| Jan 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $26.65 | $26.82 | +0.6% | +5.2% | +2.0% | +2.6% | +9.6% | +1.7% |
| Nov 6 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $31.15 | $32.90 | +5.6% | +4.8% | +2.0% | -0.1% | +1.5% | -3.0% |
| Nov 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $33.64 | $35.84 | +6.5% | -7.4% | +4.8% | +2.0% | -0.1% | +1.5% |
| Nov 5 | Baird | Maintains | Outperform → Outperform | — | $33.64 | $35.84 | +6.5% | -7.4% | +4.8% | +2.0% | -0.1% | +1.5% |
| Nov 5 | Lake Street | Maintains | Buy → Buy | — | $33.64 | $35.84 | +6.5% | -7.4% | +4.8% | +2.0% | -0.1% | +1.5% |
| Oct 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.40 | $32.48 | +0.2% | +4.3% | +2.2% | +0.4% | -4.4% | +1.5% |
| Oct 14 | BTIG | Maintains | Buy → Buy | — | $31.31 | $31.94 | +2.0% | +9.4% | -2.3% | +0.9% | -2.1% | -1.3% |
| Aug 6 | Baird | Maintains | Outperform → Outperform | — | $21.85 | $26.25 | +20.1% | +14.0% | +7.7% | +3.8% | -3.6% | -0.3% |
| Aug 6 | Stephens & Co. | Maintains | Overweight → Overweight | — | $21.85 | $26.25 | +20.1% | +14.0% | +7.7% | +3.8% | -3.6% | -0.3% |
| Jul 5 | Baird | Maintains | Outperform → Outperform | — | $21.25 | $19.13 | -10.0% | -18.1% | +3.2% | -0.6% | -2.1% | +5.8% |
| May 3 | Baird | Maintains | Outperform → Outperform | — | $22.84 | $23.50 | +2.9% | +6.5% | +0.3% | -2.5% | -1.1% | +3.7% |
| Mar 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $18.06 | $18.67 | +3.4% | +10.4% | +6.5% | +5.1% | -3.8% | -3.3% |
| Mar 1 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $18.06 | $18.67 | +3.4% | +10.4% | +6.5% | +5.1% | -3.8% | -3.3% |
| Aug 4 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $18.77 | $18.84 | +0.4% | -1.4% | -3.3% | -1.0% | -0.2% | -1.0% |
| Jul 7 | Lake Street | Maintains | Buy → Buy | — | $13.28 | $20.00 | +50.6% | +52.9% | -2.3% | -0.8% | -8.9% | -9.6% |
| Jul 6 | Stephens & Co. | Maintains | Overweight → Overweight | — | $13.70 | $13.39 | -2.3% | -3.1% | +52.9% | -2.3% | -0.8% | -8.9% |
| Jun 15 | BTIG | Maintains | Buy → Buy | — | $13.67 | $13.55 | -0.9% | -2.0% | -1.6% | +0.5% | -1.7% | +1.7% |
| Jun 7 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $14.72 | $15.13 | +2.8% | +1.3% | -3.9% | +2.3% | +0.5% | -1.9% |
| Jun 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.66 | $11.84 | +1.5% | +26.2% | +1.3% | -3.9% | +2.3% | +0.5% |
| Jun 5 | Lake Street | Maintains | Buy → Buy | — | $22.73 | $17.70 | -22.1% | -48.7% | +26.2% | +1.3% | -3.9% | +2.3% |
| Jun 5 | SVB Securities | Maintains | Outperform → Outperform | — | $22.73 | $17.70 | -22.1% | -48.7% | +26.2% | +1.3% | -3.9% | +2.3% |
| Jun 5 | Baird | Maintains | Outperform → Outperform | — | $22.73 | $17.70 | -22.1% | -48.7% | +26.2% | +1.3% | -3.9% | +2.3% |
| May 8 | Stephens & Co. | Maintains | Overweight → Overweight | — | $22.25 | $22.04 | -0.9% | +1.8% | +0.0% | +2.4% | -2.2% | +0.8% |
| May 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $22.01 | $22.46 | +2.0% | +1.1% | +1.8% | +0.0% | +2.4% | -2.2% |
| May 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $22.91 | $21.93 | -4.3% | -3.9% | +1.1% | +1.8% | +0.0% | +2.4% |
| May 4 | Baird | Maintains | Outperform → Outperform | — | $22.91 | $21.93 | -4.3% | -3.9% | +1.1% | +1.8% | +0.0% | +2.4% |
| Mar 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $22.86 | $22.50 | -1.6% | +3.4% | +4.4% | -1.6% | -6.9% | -4.1% |
| Mar 1 | Baird | Maintains | Outperform → Outperform | — | $25.18 | $25.10 | -0.3% | -9.2% | +3.4% | +4.4% | -1.6% | -6.9% |
| Jan 5 | Scotiabank | Maintains | Sector Outperform → Outperform | — | $23.14 | $24.23 | +4.7% | -1.3% | -0.2% | +2.5% | +5.8% | +3.0% |
| Nov 3 | Baird | Maintains | Outperform → Outperform | — | $24.77 | $25.93 | +4.7% | -2.0% | -9.6% | -10.2% | +2.1% | -10.1% |
| Aug 9 | Baird | Maintains | Outperform → Outperform | — | $28.48 | $32.50 | +14.1% | +7.6% | +12.0% | -0.3% | -0.8% | -1.3% |
| Aug 9 | SVB Leerink | Maintains | Market Outperform → Market Outperform | — | $28.48 | $32.50 | +14.1% | +7.6% | +12.0% | -0.3% | -0.8% | -1.3% |
| May 11 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $20.28 | $19.87 | -2.0% | -10.7% | +4.8% | +3.9% | -1.2% | +3.3% |
| May 10 | Baird | Maintains | Outperform → Outperform | — | $19.17 | $19.36 | +1.0% | +5.8% | -10.7% | +4.8% | +3.9% | -1.2% |
| May 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $19.17 | $19.36 | +1.0% | +5.8% | -10.7% | +4.8% | +3.9% | -1.2% |
| Apr 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $45.99 | $45.99 | +0.0% | -16.5% | -5.7% | -3.5% | -6.3% | -5.6% |
No insider trades available.
Data updated apr 25, 2026 3:35am
· Source: massive.com